|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 44, 1124-1131, June 2003
Copyright © 2003 by Lipid Research, Inc.


* Laboratory of Food and Biodynamics, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan
School of Humanities for Environmental Policy and Technology, Himeji Institute of Technology, Himeji 670-0092, Japan
Department of Geriatrics, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan
3 To whom correspondence should be addressed. e-mail: osawat{at}agr.nagoya-u.ac.jp
We have previously prepared the polyclonal antibody to the 13-hydroperoxyoctadecadienoic acid-modified protein (13Ab) (Kato et al. 1997. J. Lipid Res. 38: 13341346), however, the epitopes have not yet been structurally identified. In this study, we identified a novel amide-type adduct as one of the major epitopes of 13Ab and characterized the endogenous formation. Upon incubation of the lysine derivative with peroxidized linoleic acid, the formation of N
-(azelayl)lysine (AZL) was confirmed using liquid chromatography-mass spectrometry. The chemically synthesized azelayl protein was significantly recognized by 13Ab. The peroxidation products of different polyunsaturated fatty acids also generated several analogous carboxyalkylamide-type adducts to AZL by the reaction with the lysine derivative, whereas 13Ab specifically recognized AZL, suggesting that the AZL moiety may be one of the major epitopes of 13Ab. The immunoreactive materials of 13Ab were immunohistochemically detected in atherosclerotic lesions from hypercholesterolemic rabbits. More strikingly, the immunoreactivity was significantly enhanced when the sections were treated with alkali or phospholipase A2 for hydrolyzing the ester bonds prior to the staining.
These results suggest that the lipid hydroperoxide-derived carboxylic adducts, such as AZL, and their esters linked with phospholipids may be generated in vivo and involved in the pathogenesis of atherosclerosis associated with oxidative stress.
Abbreviations: AA, arachidonic acid;
-LNA,
-linolenic acid; AZL, N
-(azelayl)lysine; Bz-Gly-Lys, N
-benzoyl-glycyl-L-lysine; CML, N
-(carboxymethyl)lysine; DHA, docosahexaenoic acid; EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide; EPA, eicosapentaenoic acid; GLL, N
-(glutaroyl)lysine; HEL, N
-(hexanoyl)lysine; HNE, 4-hydroxy-2-nonenal; 15-HPETE, 15-hydroperoxyeicosatetraenoic acid; 13-HPODE, 13-hydroperoxyoctadecadienoic acid; LC-MS, liquid chromatography-mass spectrometry; MDA, malondialdehyde; sulfo-NHS, N-hydroxysulfosuccinimide; NMR, nuclear magnetic resonance; SUL, N
-(succinyl)lysine
Supplementary key words protein modification lipid peroxidation 13-hydroperoxyoctadecadienoic acid
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Kawai, H. Fujii, M. Okada, Y. Tsuchie, K. Uchida, and T. Osawa Formation of N{epsilon}-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modification J. Lipid Res., July 1, 2006; 47(7): 1386 - 1398. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |